It sounds like the US Food and Drug Administration’s roster of outside advisors is going to be kept very busy in 2023.
The FDA will have “a lot more advisory committees in 2023” than in recent years, Center for Drug Evaluation and Research Director Patrizia Cavazzoni said during a 5 April Alliance...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?